C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 9/08 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) A61P 37/06 (2006.01) C07K 16/28 (2006.01) C12N 5/10 (2006.01) C12N 15/85 (2006.01) C12P 21/08 (2006.01)
Patent
CA 2595792
The invention provides improved humanized CD20 binding antibodies for treatment of B cell malignancies and autoimmune diseases.
L'invention concerne des anticorps de liaison CD20 humanisés améliorés pour le traitement de tumeurs malignes des cellules B et de maladies auto-immunes.
Adams Camellia W.
Lowman Henry B.
Nakamura Gerald R.
Adams Camellia W.
Genentech Inc.
Lowman Henry B.
Nakamura Gerald R.
Smart & Biggar
LandOfFree
Cd20 antibody variants and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cd20 antibody variants and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd20 antibody variants and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1876046